Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-08-09

Clinical Trial Update: Study of MRA in Patients With Rheumatoid Arthritis (RA) [Phase 2]

View source ↗

Summary

Phase 2 study of MRA in rheumatoid arthritis has completed; sponsor listed is Chugai Pharmaceutical.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • MRA (MRA)

Snippet

Sponsor: Chugai Pharmaceutical | Conditions: Rheumatoid Arthritis | Phase 2 | Status: COMPLETED